Novel Methods for Reporting of Exercise Dose and Adherence: An Exploratory Analysis
| Autor: | Neil D. Eves, Jessica M. Scott, Catherine Capaci, Samantha M. Thomas, Meghan Michalski, James E. Herndon, Tormod S. Nilsen, John Sasso, Lee W. Jones |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Male
Research design medicine.medical_specialty Exercise treatment MEDLINE Physical Therapy Sports Therapy and Rehabilitation Walking Article law.invention 03 medical and health sciences Prostate cancer 0302 clinical medicine Randomized controlled trial law medicine Humans Orthopedics and Sports Medicine patient compliance / statistics & numerical data Aged Retrospective Studies Exercise Tolerance business.industry Prostatic Neoplasms Retrospective cohort study 030229 sport sciences Exploratory analysis Middle Aged medicine.disease Exercise Therapy Tolerability Research Design 030220 oncology & carcinogenesis Physical therapy Patient Compliance prostatic neoplasms / therapy business |
| Zdroj: | Medicine & Science in Sports & Exercise |
| ISSN: | 1530-0315 0195-9131 |
| DOI: | 10.1249/mss.0000000000001545 |
| Popis: | Purpose: The purpose of this study was to explore whether methods adapted from oncology pharmacological trials have utility in reporting adherence (tolerability) of exercise treatment in cancer. Methods: Using a retrospective analysis of a randomized trial, 25 prostate cancer patients received an aerobic training regimen of 72 supervised treadmill walking sessions delivered thrice weekly between 55% and 100% of exercise capacity for 24 consecutive weeks. Treatment adherence (tolerability) was assessed using conventional (lost to follow-up and attendance) and exploratory (e.g., permanent discontinuation, dose modification, and relative dose intensity) outcomes. Results: The mean total cumulative ‘‘planned’’ and ‘‘completed’’ dose was 200.7 T 47.6 and 153.8 T 68.8 METIh, respectively, equating to a mean relative dose intensity of 77% T 24%. Two patients (8%) were lost to follow-up, and mean attendance was 79%. A total of 6 (24%) of 25 patients permanently discontinued aerobic training before week 24. Aerobic training was interrupted (missing Q3 consecutive sessions) or dose reduced in a total of 11 (44%) and 24 (96%) patients, respectively; a total 185 (10%) of 1800 training sessions required dose reduction owing to both health-related (all nonserious) and non–health-related adverse events. Eighteen (72%) patients required at least one session to be terminated early; a total of 59 (3%) sessions required early termination. Conclusions: Novel methods for the conduct and reporting of exercise treatment adherence and tolerability may provide important information beyond conventional metrics in patients with cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|